Research Peptide News
Regulatory updates, clinical trial results, and industry developments in research compounds — curated for researchers. 63 articles across 5 categories.
Featured
All Articles
FDA Compounded Peptide Crackdown 2026: The Full Regulatory Timeline and What Access Looks Like Now
A detailed regulatory breakdown published by Meto Health (May 2026) traces the full timeline of FDA enforcement actions…
Drexel University Cancer Researcher Answers: Why Are Peptides Exploding in Popularity — and Are They Safe?
Drexel University's School of Biomedical Engineering published a Q&A in May 2026 with Professor Paul Brandt-Rauf, a phys…
Compounding vs. Copycat: The Patient Safety Distinction the GLP-1 Boom Exposed
The Alliance for Pharmacy Compounding (A4PC) published a direct response to Washington Post coverage of a patient who de…
UTHealth Houston Researchers Find Peptide That Seeks and Destroys Metastatic Breast Cancer Cells
Researchers at UTHealth Houston published findings in Molecular Therapy Oncology showing that a peptide called BLMP6 sel…
AI Is Now Designing Peptides From Scratch — A Shift That Could Reshape Research Compound Development
A major review published in ACS Biochemistry in April 2026 documents how artificial intelligence has fundamentally chang…
Wall Street Is Already Betting on Peptides: How Hims & Hers Is Pivoting After RFK Jr.'s Announcement
Following RFK Jr.'s April 2026 announcement that the FDA will convene a Pharmacy Compounding Advisory Committee meeting…
University Researchers Warn: Anti-Aging Peptide Trend Outpacing the Evidence
Three researchers from the University of Queensland and UNSW Sydney published a detailed safety assessment of the inject…
Annals of Internal Medicine Publishes Case Report: Retatrutide Causes Severe Intractable Diarrhea
A peer-reviewed case report published April 7, 2026 in Annals of Internal Medicine: Clinical Cases documents a dramatic…
Science.org Chemist Weighs In: What the Peptide Craze Looks Like From Inside the Lab
Derek Lowe, medicinal chemist and longtime drug industry commentator at Science.org (AAAS), published a frank assessment…
ER Doctor Writes in STAT News: Patients Are Choosing BPC-157 Over Statins — and It Reveals a Deeper Problem
A board-certified emergency physician and former U.S. Navy flight surgeon published a candid essay in STAT News in April…
Peptide Market Sees Price Compression as US Supplier Count Crosses 60 in 2026
The domestic research peptide market has grown from roughly 20 trackable suppliers in 2022 to over 60 in early 2026, acc…
FDA Approves Icotrokinra — the First Oral Targeted Peptide to Block the IL-23 Receptor
On March 18, 2026, the FDA approved Johnson & Johnson's Icotyde (icotrokinra) for moderate-to-severe plaque psoriasis —…
Longevity Researchers Are Converging on Four Peptides: Epithalon, MOTS-C, SS-31, and GHK-Cu
Analysis of 2025–2026 longevity research literature shows a convergence around four research peptides among scientists s…
Survodutide's Phase 3 MASH Trial Is the Most Watched Liver Disease Study of 2026 — Here's Why It Matters
Survodutide — a dual GLP-1 and glucagon receptor agonist developed by Boehringer Ingelheim and Zealand Pharma — is curre…
Eli Lilly's Orforglipron Approved — The First Non-Peptide Oral GLP-1 That Needs No Food Restrictions
The FDA approved Eli Lilly's orforglipron in early 2026 under an expedited National Priority Voucher pathway — making it…
UC Santa Cruz Researcher Says Overlooked Peptide P3 May Be Contributing to Alzheimer's Disease
A biochemist at UC Santa Cruz published a commentary in ChemBioChem arguing that a smaller peptide called P3 — long dism…
FDA Issues 30 Warning Letters to Telehealth Companies Over Illegal Compounded GLP-1 Marketing
On February 20, 2026, the FDA issued 30 warning letters to telehealth companies making false or misleading advertising c…
First Prospective BPC-157 Human Study Announced: Croatian Team Targets Tendon Repair
Researchers at the University of Zagreb — the institution behind much of the foundational BPC-157 preclinical work — ann…
Merck's Oral Peptide Enlicitide Cuts LDL Cholesterol 60% in Phase 3 — Could Be First Oral PCSK9 Inhibitor
Merck's enlicitide decanoate — a novel macrocyclic peptide — reduced LDL cholesterol by up to 60% in the pivotal Phase 3…
STAT News Deep Dive: What the Science on BPC-157 Actually Shows — and What It Doesn't
STAT News published a detailed investigation into BPC-157 in February 2026, finding that nearly all research originates…
Unexpected Finding: GLP-1 Peptides Showing Tumor Suppression in Pancreatic Cancer Trials
A Phase I/II trial at Johns Hopkins published in Nature Medicine in January 2026 evaluated survodutide — a dual GLP-1/GI…
Google Search Data Shows Research Compound Searches Exploded After GLP-1 Mainstream Moment
A sports medicine preprint study analyzing Google search trends from 2022 through 2025 found searches for BPC-157, CJC-1…
Sports Medicine Boom: AOSSM Highlights Growing Provider Confusion Over Research Compounds
The American Orthopaedic Society for Sports Medicine published a feature examining the rapid expansion of research compo…
USC Keck School of Medicine Publishes Injectable Peptide Therapy Guide for Sports Physicians
Researchers at the University of Southern California published a primer in the American Journal of Sports Medicine evalu…
140 Peptides Now in Active Clinical Development as Research Enters New Phase
A January 2026 review in Current Opinion in Clinical Nutrition reports that approximately 140 peptide therapeutics are c…
New Peptide CAQK Targets Injured Brain Tissue After Trauma — Human Trials Next
A global research team led by Aivocode and Spain's CSIC identified a four-amino acid peptide called CAQK that travels th…
BPC-157 Systematic Review: 36 Studies Analyzed — Here Is What the Evidence Actually Shows
A peer-reviewed systematic review published in PMC analyzed 36 studies on BPC-157 spanning 1993 to 2024 from an orthopae…
How to Reconstitute Research Peptides: Bacteriostatic Water, Storage, and Common Mistakes
Improper reconstitution and storage is the most common reason researchers get inconsistent results — and it's entirely p…
PT-141 (Bremelanotide): From Tanning Peptide Research to FDA-Approved Drug — And What That Means
Bremelanotide (PT-141) holds the unusual distinction of being a peptide that went from underground research compound to…
BPC-157 Demonstrates Accelerated Mucosal Repair in Colitis Models
New preclinical data shows BPC-157 significantly accelerates intestinal mucosal regeneration in induced colitis models,…
Second Independent Case of Hepatotoxicity Linked to Compounded Semaglutide Published at ACG 2025
A case presented at the American College of Gastroenterology 2025 Annual Meeting and published in the American Journal o…
GHK-Cu: How a Simple Tripeptide Activates Over 4,000 Genes Involved in Tissue Repair
GHK-Cu (glycine-histidine-lysine copper complex) has attracted renewed scientific interest after genomic analysis reveal…
Semaglutide-Associated Liver Injury: Peer-Reviewed Case Report Documents Probable DILI
A case report published in Oxford Medical Case Reports (2025) documents a patient who developed hepatotoxicity after usi…
Retatrutide Triple Agonist Outperforms Semaglutide on Lean Mass Preservation
Post-hoc analysis of the TRIUMPH-1 trial suggests retatrutide's triple GIP/GLP-1/glucagon agonism results in superior le…
Semax Reduces Neuroinflammatory Markers in Traumatic Brain Injury Models
Intranasal Semax administered within 6 hours of TBI significantly reduced TNF-α and IL-6 levels in cerebrospinal fluid w…
CJC-1295 + Ipamorelin: Why This Stack Became the Standard and What the Research Shows
The CJC-1295 and Ipamorelin combination has become one of the most frequently researched GH secretagogue protocols — pai…
Epithalon and Telomere Length: A Review of 20 Years of Research
A comprehensive review synthesizing two decades of Epithalon research concludes the tetrapeptide demonstrates consistent…
TB-500 Accelerates Achilles Tendon Recovery in Equine Study
TB-500 injections in thoroughbred racehorses with partial Achilles tendon tears reduced recovery time by an average of 3…
Global Therapeutic Peptide Market Projected to Reach $78B by 2030
A new industry report values the global therapeutic peptide market at $38.2B in 2024 and projects 9.4% CAGR growth throu…
Retatrutide Phase 3 Trials: Latest Updates on the Triple GLP-1/GIP/Glucagon Agonist
Retatrutide's Phase 2 data (Jastreboff et al., NEJM 2023) showed 24.2% mean weight loss at 48 weeks — surpassing tirzepa…
GHK-Cu Topical Outperforms Minoxidil in Androgenic Alopecia RCT
A 24-week randomized controlled trial found a 5% GHK-Cu topical solution produced statistically superior hair follicle d…
After the Shortage List: What Actually Happened When FDA Ended Compounded Semaglutide
The FDA removed semaglutide from the drug shortage list in October 2024, ending the legal pathway for 503A/503B compound…
Ipamorelin Improves Deep Sleep Architecture in Middle-Aged Cohort
Polysomnography data from a 30-person pilot study found nightly Ipamorelin administration for 8 weeks significantly incr…
FDA Adverse Event Database Flags Disproportionate Safety Signal for Compounded GLP-1 Receptor Agonists
A pharmacovigilance study published in Expert Opinion on Drug Safety (2025) analyzed the FDA Adverse Event Reporting Sys…
Industry Group Proposes Voluntary COA Transparency Standard for Suppliers
A newly formed industry working group released a proposed framework for voluntary certificate of analysis standards amon…
Australia Reclassifies Several Research Peptides Under Therapeutic Goods Act
The Australian TGA updated scheduling of several peptides including Melanotan II and certain GHRP compounds, tightening…
CagriSema Phase 3 Results: Novo's Amylin + GLP-1 Combo Shows ~20% Weight Loss
Novo Nordisk's REDEFINE-1 Phase 3 trial of cagrilintide/semaglutide (CagriSema) reported approximately 20.4% mean weight…
MOTS-C and Longevity: What the Research Actually Shows About This Mitochondrial Peptide
MOTS-c is encoded in mitochondrial DNA — not the nuclear genome — a fact that sets it apart from nearly every other comp…
Compare prices across 60+ research peptide suppliers